Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The influence of chemotherapy on adenosine-producing B cells in patients with head and neck squamous cell carcinoma
Andreas Ziebart, U Huber, S Jeske, et al.
Oncotarget (2017) Vol. 9, Iss. 5, pp. 5834-5847
Open Access | Times Cited: 22

Showing 22 citing articles:

Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities
Céline M. Laumont, Allyson C. Banville, Mara Gilardi, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 7, pp. 414-430
Open Access | Times Cited: 316
Role of chemotherapeutic drugs in immunomodulation of cancer
Oishi Mukherjee, Sudeshna Rakshit, Geetha Shanmugam, et al.
Current Research in Immunology (2023) Vol. 4, pp. 100068-100068
Open Access | Times Cited: 17
Adenosine-producing regulatory B cells in head and neck cancer
S Jeske, Matthias Brand, Andreas Ziebart, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 7, pp. 1205-1216
Open Access | Times Cited: 35
Effects of Chemotherapy Agents on Circulating Leukocyte Populations: Potential Implications for the Success of CAR-T Cell Therapies
Nga Truong, Tessa Gargett, Michael P. Brown, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2225-2225
Open Access | Times Cited: 30
Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer
Ryan R. Kowash, Esra A. Akbay
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
B‐cell performance in chemotherapy: Unravelling the mystery of B‐cell therapeutic potential
Zizhuo Li, Anqi Lin, Zhifei Gao, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 4
Mechanisms of induction of regulatory B cells in the tumour microenvironment and their contribution to immunosuppression and pro-tumour responses
Fabián Flores-Borja, Paul A. Blair
Clinical & Experimental Immunology (2022) Vol. 209, Iss. 1, pp. 33-45
Open Access | Times Cited: 18
Role of Mesenchymal Stem/Stromal Cells in Head and Neck Cancer—Regulatory Mechanisms of Tumorigenic and Immune Activity, Chemotherapy Resistance, and Therapeutic Benefits of Stromal Cell-Based Pharmacological Strategies
Katarzyna Starska
Cells (2024) Vol. 13, Iss. 15, pp. 1270-1270
Open Access | Times Cited: 3
The application basis of immuno-checkpoint inhibitors combined with chemotherapy in cancer treatment
Ming-Yan Shi, Han-Ge Liu, Xiaohong Chen, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 8
Comparison of peripheral blood mononuclear cell isolation techniques and the impact of cryopreservation on human lymphocytes expressing CD39 and CD73
Ross J. Turner, Nicholas J. Geraghty, Jonathan G. Williams, et al.
Purinergic Signalling (2020) Vol. 16, Iss. 3, pp. 389-401
Open Access | Times Cited: 20
Direct Immunoactivation by Chemotherapeutic Drugs in Cancer Treatment
Yurui Wang, Yiran Song, Yazhi He, et al.
Advanced Therapeutics (2023) Vol. 6, Iss. 12
Open Access | Times Cited: 4
Treatment-induced changes of lymphocyte subsets in patients with adenoid cystic carcinoma of the head and neck
S Jeske, Stephanie E. Weissinger, J. Veit, et al.
European Archives of Oto-Rhino-Laryngology (2019) Vol. 276, Iss. 5, pp. 1465-1473
Closed Access | Times Cited: 12
ADA/CD26 axis increases intra-tumor PD-1 + CD28 + CD8 + T-cell fitness and affects NSCLC prognosis and response to ICB
Ornella Franzese, Belinda Palermo, Giuseppe Frisullo, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
The Dichotomous Role of Bone Marrow Derived Cells in the Chemotherapy-Treated Tumor Microenvironment
Avital Vorontsova, Tal Kan, Ziv Raviv, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3912-3912
Open Access | Times Cited: 9
Adenosine production in mesenchymal stromal cells in relation to their developmental status
S Jeske, Marie‐Nicole Theodoraki, Edwin Boelke, et al.
HNO (2020) Vol. 68, Iss. 2, pp. 87-93
Closed Access | Times Cited: 8
Low Pretreatment CD4+:CD8+ T Cell Ratios and CD39+CD73+CD19+ B Cell Proportions Are Associated with Improved Relapse-Free Survival in Head and Neck Squamous Cell Carcinoma
Ross J. Turner, Thomas V. Guy, Nicholas J. Geraghty, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12538-12538
Open Access | Times Cited: 2
B Cells in the Gastrointestinal Tumor Microenvironment with a Focus on Pancreatic Cancer: Opportunities for Precision Medicine?
Dário Ligeiro, Martin Rao, Andreia Maia, et al.
Advances in experimental medicine and biology (2020), pp. 175-195
Closed Access | Times Cited: 3
B-Zellen in der Kopf-Hals-Onkologie
Patrick J. Schuler, Cornelia Brunner, Thomas Hoffmann
HNO (2018) Vol. 66, Iss. 4, pp. 296-300
Closed Access | Times Cited: 2
Translational Learnings in the Development of Chemo-Immunotherapy Combination to Bypass the Cold Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma
Hélène Kaplon
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 1
The Multifaceted Roles of Ketogenic Diets in Neurology-Brain Cancers and Other Neurologic Diseases
Abdullah S. Binsaeedu, Moustafa Khalifa, Jocelyn Tan-Shalaby
Recent Progress in Nutrition (2023) Vol. 03, Iss. 02, pp. 1-15
Open Access
El sistema inmune y el microambiente tumoral: componentes y función
José Sanz, Ana M. Gómez-Lahoz, A. Silva
Medicine - Programa de Formación Médica Continuada Acreditado (2021) Vol. 13, Iss. 33, pp. 1932-1941
Closed Access
Auswirkungen von Chemotherapeutika auf zirkulierende Leukozytenpopulationen: Mögliche Implikationen für den Erfolg von CAR-T-Zell-Therapien
Nga Truong, Tessa Gargett, Michael P. Brown, et al.
Kompass Onkologie (2021) Vol. 8, Iss. 3, pp. 116-127
Closed Access
Page 1

Scroll to top